Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FyMed Demonstrates Superiority of FY101C over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed Demonstrates Superiority of FY101C over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed Demonstrates Superiority of FY101C over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
Submitted by
admin
on July 23, 2012 - 10:16pm
Source:
CP Wire
News Tags:
FY101C
fymed
painkillers
NSAIDs
chronic pain
Headline:
FyMed Demonstrates Superiority of FY101C over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
Do Not Allow Advertisers to Use My Personal information
